All sponsors

Almirall, S.A. $ALM.MC

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-33
RECRUITING4
READOUTS ≤12 MONTHS4
Open Almirall, S.A. on the live radar map → 📅 $ALM.MC readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
LAD328
NCT07547813
P2RecruitingHidradenitis Suppurativa502027-02
ADhope 2
NCT06526182
P3Active, not recruitingDermatitis, Atopic; Eczema5202027-04-25 (+13 mo)
LAD191
NCT07151937
P2RecruitingHidradenitis Suppurativa2002027-05-25
LAD603
NCT07311564
P2RecruitingAlopecia Areata1362027-06-23
ADface
NCT07873801
P3Not yet recruitingAtopic Dermatitis2302028-02
LUMINE
NCT07542483
P3RecruitingNummular Eczema2702028-08